Inhibition of CDC25B With WG-391D Impedes the Tumorigenesis of Ovarian Cancer

Novel inhibitors are urgently needed for use as targeted therapies to improve the overall survival (OS) of patients with ovarian cancer. Here, we show that cell division cycle 25B (CDC25B) is over-expressed in ovarian tumors and associated with poor patient prognosis. All previously reported CDC25B...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiao, Yangjiong, Yu, Yang, Gao, Dan, Jin, Wangrui, Jiang, Pengcheng, Li, Yuhong, Wang, Chao, Song, Yuning, Zhan, Peng, Gu, Fei, Zhang, Cancan, Wang, Bin, Chen, Yihua, Du, Bing, Zhang, Rong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6463794/
https://www.ncbi.nlm.nih.gov/pubmed/31024841
http://dx.doi.org/10.3389/fonc.2019.00236

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6463794/
https://www.ncbi.nlm.nih.gov/pubmed/31024841
http://dx.doi.org/10.3389/fonc.2019.00236

Ejemplares similares